share_log

Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15

Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15

拉登堡塔爾曼以買入評級啓動對Peak Bio的報道,宣佈目標股價爲15美元
Benzinga Real-time News ·  2022/11/04 07:24

Ladenburg Thalmann analyst Ahu Demir initiates coverage on Peak Bio (NASDAQ:PKBO) with a Buy rating and announces Price Target of $15.

拉登堡塔爾曼分析師阿胡·德米爾以買入評級啓動了對Peak Bio(納斯達克股票代碼:PKBO)的報道,並宣佈目標股價爲15美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論